Jove
Visualize
Contact Us

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

809
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
809
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.1K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

15
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
15
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

46
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
46
Probability Laws01:49

Probability Laws

41.2K
Overview
41.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of COVID-19 Pandemic on Diabetic Foot Ulcer Management in Kalamazoo, Michigan.

Journal of the American Podiatric Medical Association·2025
Same author

Digital Accommodations for Students Living with Print Disabilities: A Literature Review.

Medical reference services quarterly·2020
Same author

Entrustable professional activity 7: opportunities to collaborate on evidence-based medicine teaching and assessment of medical students.

BMC medical education·2019
Same author

Myiasis infestation superimposed on pacemaker infection.

Acta cardiologica·2019
Same author

Building new twenty-first century medical school libraries from the ground up: challenges, experiences, and lessons learned.

Journal of the Medical Library Association : JMLA·2019
Same author

Allopurinol, xanthine oxidase, and cardiac ischemia.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2009
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Aug 9, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.1K

Prothrombin Gene Mutation as a Teaching Tool: An Autobiographical Case Report.

Tucker Morris1, Elizabeth R Lorbeer2, Richard R Roach3

  • 1Department of Medical Education, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, USA.

Cureus
|February 23, 2023
PubMed
Summary
This summary is machine-generated.

Prothrombin G20210A mutation carriers face thrombotic risks. This case highlights severe postoperative complications including DVT, PVT, and PE, emphasizing careful management for mutation carriers.

Area of Science:

  • Genetics
  • Hematology
  • Vascular Surgery

Background:

  • Prothrombin G20210A mutation is a known risk factor for thrombotic events.
Keywords:
blood clotcholecystectomyportal vein thrombosisprothrombin g20210a factor ii mutationpulmonary embolization

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.1K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.1K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.1K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K
  • Genetic screening identifies carriers, but clinical manifestations can vary.
  • Pregnancy and surgical interventions can exacerbate thrombotic risks in carriers.